MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Levodopa Initiation in Phase 3 Trials of Tavapadon, a Selective D1/D5 Agonist for Early Parkinson’s Disease

    W. Ondo, G. Stebbins, J. Eubanks, M. Rollins Hatcher, T. Nicholson, J. Ma (Houston, USA)

  • Levodopa Responsiveness and Motor Complication Trajectories in Parkinson’s Disease by α-Synuclein Seed Amplification Assay Status

    H. Azizi, SM. Fereshtehnejad, R. Moqadam, M. Dadar, A. Siderowf, A. Dagher, Y. Zeighami (Montreal, Canada)

  • Levodopa-Carbidopa Intestinal Gel Infusion Therapy in Advanced Parkinson’s Disease: Extension Study of Long-term outcomes of Single Centre experience

    H. Alhodaif, Y. Alkhodair, S. Alqahtani, B. Bohlega, A. Aldakheel (Riyhadh, Saudi Arabia)

  • Levodopa-Induced Dyskinesia Predicts Falls, Fall-Related Injuries, and Their Consequences in Parkinson’s Disease: A Prospective PPMI Cohort Study

    P. Pelicioni, L. Santos, S. Freitas, P. Nobrega-Sousa, K. Delbaere (Randwick, Australia)

  • Levodopa-Induced Dyskinesias in Patients with Parkinson’s Disease in the Uzbek Population

    G. Isroilova, Z. Sayfitdinkhuzhaev (Tashkent, Uzbekistan)

  • Levodopa-induced peak-dyskinesia and motor fluctuations in corticobasal syndrome

    N. Caballol, A. Cámara, L. Planellas, C. Painous, A. Peral, A. Planas-Ballvé, P. Lombardo, A. ávila, Y. Compta (Sant Joan Despí, Spain)

  • Levodopa-Responsive Dystonia in Adenylosuccinate Lyase (ADSL) Deficiency Treated With Bilateral GPi Deep Brain Stimulation

    K. Ibarra, M. San Luciano (San Francisco, USA)

  • Levodopa–Entacapone–Carbidopa Intestinal Gel (LECIG) Provides Sustained Improvement In Quality Of Life In Advanced Parkinson’s For Up To Two Years

    S. Singh, N. Smith, B. Amlani (Reading, United Kingdom)

  • Levodopa–Entacapone–Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: a Four-Year Real-Life Experience

    J. Szasz, V. Constantin, K. Orban Kis, R. Szasz, S. Bataga, R. Neagoe, M. Ciorba, K. Kelemen, I. Mihaly, K. Biro, S. Szatmari (TARGU MURES, Romania)

  • LFP-Based Deep Brain Stimulation Programming and Transition to Adaptive Deep Brain Stimulation in a Patient with Parkinson’s Disease: A Case Report from Thailand

    O. Phokaewvarangkul, N. Likhitwitayawuid, K. Sanyawut, N. Rattanapitak, R. Bhidayasiri (Bangkok, Thailand)

  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 208
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley